High resolution computed tomography as a predictor of lung histology in systemic sclerosis

A U Wells, D M Hansell, B Corrin, N K Harrison, P Goldstraw, C M Black, R M du Bois

National Heart and Lung Institute, Royal Brompton National Heart and Lung Hospital, London SW3 6NP
Royal Free Hospital, London NW3 2QG

Background The relative proportions of fibrosis and inflammation seen by open lung biopsy examination is a predictor of disease outcome in fibrosing alveolitis. This study was designed to assess the ability of high resolution computed tomography to predict the histological appearance of open lung biopsy specimens from patients with systemic sclerosis.

Methods Twenty abnormal biopsy specimens from 12 patients were assessed; abnormalities were categorised as fibrotic (fibrosis exceeding inflammation) or inflammatory (inflammation equal to or exceeding fibrosis). Computed tomography appearances were scored for the lobe from which the biopsy specimen was taken; scans were graded from parenchymal opacification alone through to a reticular pattern alone.

Results Two lobar appearances were identified on computed tomograms: amorphous parenchymal opacification equal in extent to reticulation (grade 3) and a predominantly reticular pattern (grade 4). There was a significant association between a fibrotic histological appearance and a grade 4 computed tomogram, and between an inflammatory histological appearance and a grade 3 computed tomogram. Computed tomography grade 4 was associated with a fibrotic histological appearance in 12 out of 13 lobes, and grade 3 with an inflammatory histological appearance in four out of seven lobes.

Conclusion Computed tomography discriminated between biopsy specimens that were predominantly fibrotic and a smaller group with a larger amount of inflammation.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Savarino, E., Bazzica, M., Zentilin, P., Pohl, D., Parodi, A., Cittadini, G., Negrini, S., Indiveri, F., Tutuian, R., Savarino, V., Ghio, M. (2009). Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma: A Study Using pH-Impedance Monitoring. Am. J. Respir. Crit. Care Med. 179: 408-413 [Abstract] [Full Text]  
• Kim, E. A, Lee, K. S., Johkoh, T., Kim, T. S., Suh, G. Y., Kwon, O J., Han, J. (2002). Interstitial Lung Diseases Associated with Collagen Vascular Diseases: Radiologic and Histopathologic Findings. RadioGraphics 22: S151-165 [Abstract] [Full Text]  
• Diot, E., Giraudeau, B., Diot, P., Degenne, D., Ritz, L., Guilmot, J.-L., Lemarie, E. (1999). Is Anti-Topoisomerase I a Serum Marker of Pulmonary Involvement in Systemic Sclerosis?. Chest 116: 715-720 [Abstract] [Full Text]  
• Wells, A. (1998). Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis. Thorax 53: 1080-1087 [Full Text]  
• Witt, C., Domer, T., Hiepe, F., Borges, A., Fietze, I., Baumann, G. (1996). Diagnosis of alveolitis in interstitial lung manifestation in connective tissue diseases: importance of late inspiratory crackles, 67 gallium scan and bronchoalveolar lavage. Lupus 5: 606-612 [Abstract]  
• SOCIETY, B. T., COMMITTEE, S. O. C. (1990). The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults---British Thoracic Society recommendations. Thorax 54: 1S-28 [Full Text]